Zimmer Biomet Beats Analyst Expectations in Q1

Zimmer Biomet saw hip and knee procedure volumes bounce back in the first quarter, but whether or not the recovery is sustained beyond Q1 remains to be seen, given multiple headwinds. Still, the Warsaw, IN-based orthopedic device company raised its 2022 revenue and earnings guidance.